HOW THE PROGRAM WORKS
Research for the Minor Use Animal Drug Program [MUADP] is funded through a USDA special research grant.
MUADP also receives support from pharmaceutical firms, universities, and State Agricultural Experiment Stations.
Research projects are initiated by requests (usually from researchers or animal producers) to the program’s regional
coordinators to address a particular minor use drug need. These requests, known as ADR’s (Animal Drug Request), are
prioritized according to financial and regulatory feasibility, importance to the animal industry, and the pharmaceutical
manufacturer’s commitment to the minor use drug approval.
Once a request is accepted as a research project, study protocols are developed.
Research is conducted in accordance with FDA’s Good Laboratory Practices regulations.
A successful research project is submitted to FDA’s Center for Veterinary Medicine as a public master file,
and the availability of the data in the public master files is published in the Federal Register.
A pharmaceutical sponsor may then reference, at no cost, the data in the public master files to support
a new animal drug application for the minor use.
The final step in the process is FDA approval of this application from the pharmaceutical sponsor,
so that the product may be labeled and sold for the minor use.
MUADP is composed of a Technical Committee
and one Administrative Advisor
The Administrative Advisor is an Experiment Station Director who provides liaison between the Directors of the State Agricultural Experiment Stations,
USDA/NIFA, FDA/CVM, various animal organizations, and others coordinating the efforts of this program.
The Administrative Advisor also provides advice on policy, budget, and administrative matters.
The Technical Committee is composed of the following representatives:
- National Animal Drug Coordinator
- Regional Animal Drug Coordinator from each of four regions
- Administrative Advisor (non-voting)
- USDA/NIFA representative (non-voting)
- FDA/CVM representative (non-voting)
The Technical Committee conducts the affairs of NECC1702 Minor Use Animal Drug Program, including such matters as
prioritizing projects, planning workshops, and funding and overseeing the progress of individual drug projects.